Nuvectis Pharma Inc
NVCT
NASDAQ
Biotechnology
$18.96
USD
-0.27 (-1.40%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $626.54M
Volume 106.7K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
FTH | Faeth Therapeutics, Inc | $738.26M | - | - | - | |
STTK | Shattuck Labs Inc | $645.26M | - | -78.3% | - | |
TECX | Tectonic Therapeutic Inc | $635.35M | - | - | - | |
CBIO | Crescent Biopharma Inc | $625.50M | - | - | - | |
MDXG | MiMedx Group Inc | $622.40M | 99.76 | -2.4% | - | |
NVCT | Nuvectis Pharma Inc | $614.98M | - | - | - | |
SPRY | ARS Pharmaceuticals Inc | $586.88M | - | +1.9% | - | |
ALT | Altimmune Inc | $586.09M | - | +80.0% | - | |
SGMT | Sagimet Biosciences Inc | $585.53M | - | - | - | |
FDMT | 4D Molecular Therapeutics Inc | $582.36M | - | +383560.9% | - | |
PRME | Prime Medicine Inc | $571.34M | - | -17.9% | - |
Top Peer by Growth
4D Molecular Therapeutics Inc
+383560.9% YoY Revenue
Lowest P/E Ratio
MiMedx Group Inc
98.12x P/E
Best 1-Year Return
Artiva Biotherapeutics Inc
+366.8% Return